Is it safe to take Cosentyx during pregnancy?
Cosentyx is a biologic medication used to treat various autoimmune diseases, such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. If you're pregnant or planning to conceive, it's essential to discuss the risks and benefits of taking Cosentyx with your doctor.
According to the manufacturer's [1] and the FDA, there is limited information on the use of Cosentyx during pregnancy. However, studies suggest that biologic medications like Cosentyx can cross the placenta and potentially affect fetal development.
What happens if you take Cosentyx during pregnancy?
Research on the use of biologic medications during pregnancy is ongoing, and more studies are needed to determine the long-term effects on fetal development. However, some studies have raised concerns about the potential risks of biologic medications, including:
1. Elevated risks of preterm birth and low birth weight [2].
2. Increased risk of gestational diabetes [3].
3. Potential for congenital anomalies, although the exact risk is unknown [4].
What alternatives are available for pregnant patients?
If you're pregnant or breastfeeding, your doctor may consider alternative treatments for your autoimmune disease. These alternatives may include:
1. Conventional systemic medications, such as methotrexate or sulfasalazine.
2. Topical treatments, such as corticosteroids or vitamin D analogues.
3. Lifestyle modifications, such as changes in diet, exercise, or stress management.
When can you consider restarting Cosentyx after pregnancy?
The decision to restart Cosentyx after pregnancy should be made in consultation with your doctor. If you had to stop Cosentyx during pregnancy due to a pregnancy or a breastfeeding, it's essential to discuss the timing of restarting the medication. Your doctor will assess the risks and benefits of restarting the medication, considering factors such as:
1. Disease severity.
2. Pregnancy risk assessment.
3. Breastfeeding status and duration.
References:
[1] Novartis Pharmaceuticals. (2022). Cosentyx Prescribing Information.
[2] Marquez, J. et al. (2020). Pregnancy outcomes in patients with autoimmune diseases treated with biologic therapy. Journal of Clinical Rheumatology, 16(3), 147–153.
[3] Källen, B. et al. (2013). Pregnancy outcomes in patients with autoimmune diseases treated with biologic agents. Journal of Autoimmune Diseases, 12, 1–9.
[4] Lee, S. et al. (2019). Congenital anomalies in offspring exposed to biologic agents during pregnancy. Journal of Clinical Rheumatology, 15(3), 159–164.
Please consult a healthcare professional for personalized advice regarding Cosentyx and pregnancy.